TransMedics Group Inc (TMDX)
TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
TMDX SEC Filing Email Alerts Service
| Company Name: |
TransMedics Group Inc |
| Website: |
www.transmedics.com |
| Sector: |
Medical Instruments & Supplies |
| Number of ETFs Holding TMDX: |
30 |
| Total Market Value Held by ETFs: |
$276.08M |
| Total Market Capitalization: |
$3.05B |
| % of Market Cap. Held by ETFs: |
9.04% |
|
|
April 18, 2024 • 10:49 PM Eastern
Strong Buy (3.71 out of 4)
100th percentile
|
|
Free TMDX Email Alerts:
